Home > Annual Financials > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
[BOM: 532872|NSE : SPARC]

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]

ConsolidatedMar2024
Mar2023
Operating Income ₹76 Cr₹239 Cr
Operating Expenses ₹140 Cr₹180 Cr
Expenses ₹478 Cr₹453 Cr
Operating Profit (Excl OI) ₹-402 Cr₹-214 Cr
Other Income ₹29 Cr₹11 Cr
Interest ₹1.70 Cr₹7.64 Cr
Depreciation ₹13 Cr₹12 Cr
Profit Before Tax ₹-387 Cr₹-223 Cr
Profit After Tax ₹-387 Cr₹-223 Cr
Consolidated Net Profit ₹-387 Cr₹-223 Cr
Earnings Per Share (Rs)₹-11.93₹-6.86
PAT Margin (%)-512.56-93.22
ROE(%)-121.28-43.41
ROCE(%)-112.35-41.91
Total Debt/Equity(x)0.370.00

Key Financials

Market Cap : ₹ 5,417.5 Cr
Revenue (TTM) : ₹ 71.8 Cr
Net Profit(TTM) : ₹ -342.5 Cr
EPS (TTM) : ₹ -10.6
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY -14.7% 18.5% -17.9%
SYNGENE INTERNATIONAL 2.7% 7% -2.5%
SAGILITY INDIA 5.5% -0.5% NA
LATENT VIEW ANALYTICS 0% 0.7% -10.9%
JUST DIAL 2.6% 3.9% -2.4%
AWFIS SPACE SOLUTIONS 2.7% 16% 70.1%
MEDI ASSIST HEALTHCARE SERVICES 0.6% 13.5% 9.8%
JAYKAY ENTERPRISES 6.2% 19.4% 145.2%
ECOS (INDIA) MOBILITY & HOSPITALITY 7.8% 59.1% NA


SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]

Y-o-Y

-68.36 %

5 Yr CAGR

-68.36 %

Years Revenues % Change
Mar2024 ₹76 Cr
-68.36
Mar2023 ₹239 Cr -


SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-402 Cr
Negative
Mar2023 ₹-214 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -532.26%
Negative
Mar2023 -89.65% -

SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-387 Cr
Negative
Mar2023 ₹-223 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -512.56 %
Negative
Mar2023 -93.22 % -

SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-12
Negative
Mar2023 ₹-6.86 -

SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -112.35%
Negative
Mar2023 -41.91% -

SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Current Share Price : ₹167.0
Current MarketCap: ₹ 5,417.5 Cr
Updated EOD on :Jun 09,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-14.7%

18.5%

-17.9%

SENSEX

1.3%

2.6%

7.8%

SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE 250 SMALLCAP INDEX 3.2% 14.7% 9.1%
BSE 400 MIDSMALLCAP INDEX 3% 12.2% 8.2%
BSE SMALLCAP 2.8% 15.3% 12.1%
NSE Indices1W1M1Y
NIFTY TOTAL MARKET 2.2% 7.1% 7.3%
NIFTY MICROCAP 250 2.1% 15.5% 14%

You may also like the below Video Courses


FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials


How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .

How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?

The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY .